| ACRS Snapshot | |
|---|---|
| Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a line of novel small molecule therapeutics to address the needs of patients with immuno-inflammatory diseases. The company is headquartered in Wayne, Pennsylvania. | |
| VALUATION DATA | |
| Market Capitalization | $83,337,000 | Price to Sales | 8.00 |
| Earnings per Share | $-1.2700 |
| PE Ratio | None |
| PRICE DATA | |
| Most Recent Close | $1.1900 |
| 52 Week High | $2.746 |
| 52 Week Low | $0.546 |
| 50-Day Moving Average | $35.36 |
| 200-Day Moving Average | $0.285 |
| All data are from Alpha Vantage as of today. For more infomation on ACRS see Stock Dividend, Valuation, Price and Financial Data for Investors | |
Custom Search